Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Meibergdreef 15, Amsterdam, The Netherlands.
Antiviral Res. 2010 May;86(2):204-11. doi: 10.1016/j.antiviral.2010.02.320. Epub 2010 Feb 25.
Gene silencing by RNA interference (RNAi) can be achieved by intracellular expression of a short hairpin RNA (shRNA) that is processed into the effective small interfering RNA (siRNA) inhibitor by the RNAi machinery. Previous studies indicate that shRNA molecules do not always reflect the activity of corresponding synthetic siRNAs that attack the same target sequence. One obvious difference between these two effector molecules is the hairpin loop of the shRNA. Most studies use the original shRNA design of the pSuper system, but no extensive study regarding optimization of the shRNA loop sequence has been performed. We tested the impact of different hairpin loop sequences, varying in size and structure, on the activity of a set of shRNAs targeting HIV-1. We were able to transform weak inhibitors into intermediate or even strong shRNA inhibitors by replacing the loop sequence. We demonstrate that the efficacy of these optimized shRNA inhibitors is improved significantly in different cell types due to increased siRNA production. These results indicate that the loop sequence is an essential part of the shRNA design. The optimized shRNA loop sequence is generally applicable for RNAi knockdown studies, and will allow us to develop a more potent gene therapy against HIV-1.
RNA 干扰(RNAi)的基因沉默可以通过细胞内表达短发夹 RNA(shRNA)来实现,该 shRNA 被 RNAi 机制加工成有效的小干扰 RNA(siRNA)抑制剂。先前的研究表明,shRNA 分子并不总是反映出攻击相同靶序列的相应合成 siRNA 的活性。这两种效应分子之间的一个明显区别是 shRNA 的发夹环。大多数研究使用 pSuper 系统的原始 shRNA 设计,但尚未对 shRNA 环序列的优化进行广泛研究。我们测试了不同大小和结构的发夹环序列对靶向 HIV-1 的一组 shRNA 的活性的影响。我们能够通过替换环序列将弱抑制剂转化为中等甚至强 shRNA 抑制剂。我们证明,由于 siRNA 产量增加,这些优化的 shRNA 抑制剂在不同细胞类型中的功效显著提高。这些结果表明,环序列是 shRNA 设计的重要组成部分。优化的 shRNA 环序列通常适用于 RNAi 敲低研究,并将使我们能够开发更有效的针对 HIV-1 的基因治疗方法。